Literature DB >> 2987252

Stimulation of rat ovarian cell steroidogenesis by high density lipoproteins modified with tetranitromethane.

J E Nestler, G K Chacko, J F Strauss.   

Abstract

Human high density lipoprotein (devoid of apo-E) was modified by nitration of tyrosine residues with tetranitromethane. As a result of extensive cross-linking, monomeric apo-A-I was markedly depleted, as assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and the modified HDL did not effectively bind to high-affinity sites present on dispersed rat ovarian cells and isolated rat ovarian membranes. Nonetheless, the modified HDL retained the ability to stimulate steroidogenesis by both dispersed rat ovarian cells and cultured rat granulosa cells to a degree at least equal to that of native HDL. Modified HDL stimulated luteal steroidogenesis under basal conditions and when cells were stimulated with luteinizing hormone or 8-bromo-cAMP. Although modified HDL did not effectively bind to high-affinity sites, it exhibited substantial "nonspecific" or "low-affinity" binding which was not displaceable by native HDL. These data suggest that high-affinity binding is not an essential event in the "HDL pathway" and that HDL can deliver its sterols through low-affinity cellular associations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987252

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  2 in total

1.  Interaction in vivo and in vitro of apolipoprotein E-free high-density lipoprotein with parenchymal, endothelial and Kupffer cells from rat liver.

Authors:  D Schouten; M Kleinherenbrink-Stins; A Brouwer; D L Knook; T J Van Berkel
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

2.  High density lipoproteins from bovine plasma and follicular fluid do not possess a high affinity for glycosaminoglycans.

Authors:  S A Brantmeier; R R Grummer; R L Ax
Journal:  Lipids       Date:  1988-04       Impact factor: 1.880

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.